# US 2019/0336548 A1 · Lactobacillus supplement for promoting gastric and immune health

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0336548 A1
- Document ID: US20190336548A1
- Status: Published application
- Kind: A1
- Application number: 16/470,802
- Filed: 2017-12-18
- Published: 2019-11-07
- Earliest claimed: 2016-12-18
- Assignees: University of Florida Research Foundation, Inc.
- Applicants: University of Florida Research Foundation, Inc.
- Inventors: Graciela Liliana LORCA; Claudio GONZALEZ
- Web page: https://patentgrep.com/patent/US20190336548A1

## CPC

- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/50: Microcapsules {having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals (A61K9/2081 takes precedence; particles with a single coating comprising drug A61K9/167)}
- A61P 1/14: Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2400/151: Johnsonii
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The subject invention provides compositions for promoting good health. Specifically, the subject composition can be used for alleviating symptoms of indigestion, abdominal pain, and cephalic syndrome, including in healthy subjects. In preferred embodiments, the compositions comprise an effective amount of one or more Lactobacillus isolates. Preferably, the bacteria used as an active ingredient in the compositions of the subject invention are of the L. johnsonii N6.2 strain. The subject invention also provides methods for alleviating symptoms of indigestion, abdominal pain, and cephalic syndrome. These methods comprise the administration of a composition of the subject invention, wherein the composition preferably comprises an effective amount of one or more Lactobacillus isolates. Even more preferably, the subject method utilizes an effective amount of L. johnsonii N6.2.

## Claims

### Claim 1

A probiotic composition comprising Lactobacillus johnsonii N6.2 and a pharmaceutically acceptable carrier.

### Claim 2 (depends on 1)

The probiotic composition of claim 1, wherein the composition is a food.

### Claim 3 (depends on 1, 2)

The probiotic composition of claim 1 or 2, wherein the food is a fermented food.

### Claim 4

The probiotic composition of any preceding claim, wherein the composition is a dried powder.

### Claim 5 (depends on 4)

The probiotic composition of claim 4, wherein the dried powder is encapsulated in a capsule.

### Claim 6 (depends on 5)

The probiotic composition of claim 5, wherein the capsule is acid resistant.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the capsule contains about 108 CFU of Lactobacillus johnsonii N6.2.

### Claim 8

A method for alleviating symptoms of indigestion, abdominal pain or cephalic syndrome in a subject, comprising administering to the subject a composition comprising an effective amount Lactobacillus johnsonii N6.2.

### Claim 9 (depends on 8)

The method of claim 8, wherein the subject has not been diagnosed with type 1 diabetes.

### Claim 10 (depends on 8, 9)

The method of claim 8 or 9, comprising orally administering the composition to the subject.

### Claim 11 (depends on 8, 9, 10)

The method of any of claims 8 to 10, wherein the composition is a food.

### Claim 12 (depends on 11)

The method of claim 11, wherein the food is a fermented food.

### Claim 13 (depends on 8, 9, 10, 11, 12)

The method of any of claims 8 to 12, wherein the composition is a dried powder.

### Claim 14 (depends on 13)

The method of claim 13, wherein the dried powder is encapsulated in a capsule.

### Claim 15 (depends on 14)

The method of claim 14, wherein the capsule is acid resistant.

### Claim 16 (depends on 15)

The method of claim 15, wherein the capsule contains about 108 CFU of Lactobacillus johnsonii N6.2.

### Claim 17 (depends on 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method of any of claims 8 to 16, wherein said administering increases serum tryptophan levels in the subject.

### Claim 18 (depends on 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any of claims 8 to 17, wherein said administering decreases kynurenine:tryptophan (K:T) ratio in the subject.

### Claim 19 (depends on 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The method of any of claims 8 to 18, wherein said administering increases circulating levels of Immunoglobulin A (IgA) in the subject.
